Skip to content
Snippets Groups Projects
Commit 35e52275 authored by Wu Zhiling's avatar Wu Zhiling
Browse files

Update file human-practices.tsx

parent 8fa98c3d
No related branches found
No related tags found
No related merge requests found
Pipeline #434261 passed
......@@ -111,8 +111,14 @@ export function HumanPractices() {
<h2>Section 5</h2>
<p>Content for section 5.</p>
<div className="rounded-border">
<h4 className="center-text">我是大帅B</h4>
<p className="indent">las ijffs aiskfd fskj iiwls asd.aass ffas awssd awus iisal fask.aisisad ksjdfkaf iwjasifjakdshf wijdfalksjf wiksjkfjksalhf, gsahfjhgejkfh uhaejkfh sjdihgfuqiw jh sjiafhjsaj fh asd.</p>
<h4 className="center-text">STAKEHOLDER</h4>
<p className="indent">Stakeholder Identification
Our iGEM project, focusing on innovative treatment for hepatic encephalopathy (HE), has identified key stakeholders critical to the success and real-world application of our research. These stakeholders include HE patients, medical professionals (doctors), pharmaceutical company representatives, research experts involved in HE-related studies, and the general public.
Patients: Suffering from HE represent a primary stakeholder, as their quality of life directly depends on effective treatment options.
Doctors: Especially hepatologists and neurologists, are integral in diagnosing and treating HE, providing us with valuable insights into clinical needs.
Pharmaceutical company representatives: They are vital for translating research into market-ready therapies, ensuring accessibility and scalability of our solutions.
Researchers: Including academics and specialists in liver disease, are critical for guiding the scientific direction of the project.
General public: As raising awareness and educating people about HE can significantly contribute to early diagnosis and treatment, ultimately benefiting the healthcare ecosystem as a whole.</p>
<p className="indent">las ijffs aiskfd fskj iiwls asd.aass ffas awssd awus iisal fask.aisisad ksjdfkaf iwjasifjakdshf wijdfalksjf wiksjkfjksalhf, gsahfjhgejkfh uhaejkfh sjdihgfuqiw jh sjiafhjsaj fh asd.</p>
</div>
</Element>
......
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment